key: cord-0830825-qawb1fnm authors: Palermo, Giovanni; Tommasini, Luca; Baldacci, Filippo; Del Prete, Eleonora; Siciliano, Gabriele; Ceravolo, Roberto title: Impact of COVID‐19 pandemic on cognition in Parkinson's disease date: 2020-08-10 journal: Mov Disord DOI: 10.1002/mds.28254 sha: a84c56af62baadc3cbcb313dd8f5c059b8edc59d doc_id: 830825 cord_uid: qawb1fnm nan The COVID-19 pandemic has been rapidly pressing in several countries and the ability to provide standard neurological care has been compromised by the strain on health care systems 1 . We currently have no specific therapeutics or vaccines and we need to rely on rigorous implementation of traditional public health measures, such as isolation, quarantine and social distancing to tackle the spread of the outbreak. There are particular concerns around the increased vulnerability of patients living with neurodegenerative diseases, such as Parkinson's disease (PD), and this is not restricted to those who happen to become infected by the virus 2,3 . The adoption of unprecedented preventive social measures over a very short period exerted unintended secondary effects, especially on people with chronic neurological diseases which require a continuous care and psychosocial support. Contradictory results have been reported on COVID-19 risk and mortality in PD patients [4] [5] [6] , but few studies focused on the possible indirect impact in this population 2, 7 . As the acute phase of the crisis subsided, from June 1, 2020, to July 15, 2020 we have seen at the Movement Disorders outpatient clinic in Pisa, Italy, 28 PD patients with cognitive disturbances (10 PD with subjective cognitive complaints -SCI-10 PD with mild cognitive impairment -MCIand 8 PD with dementia -PDD) (Table) . To minimize the effect of PD progression on the change in cognition, in this report we included only patients who performed their last clinical assessment No specific funding was received for this work. The authors declare that there are no conflicts of interest relevant to this work. We confirm that we have read the Journal's position on issues involved in ethical publication and affirm that this work is consistent with those guidelines. We also guarantee that patients have given their consent to anonymously report their clinical reports in accordance with current ethical standards. This article is protected by copyright. All rights reserved. Movement Disorders in the World of COVID-19 Mental Health, Physical Activity, and Quality of Life in Parkinson's Disease During COVID-19 Pandemic Parkinson's Disease and COVID-19: Perceptions and Implications in Patients and Caregivers Outcome of Parkinson's Disease Patients Affected by COVID-19 Effects of COVID-19 on Parkinson's Disease Clinical Features: A Community-Based Case-Control Study COVID-19 in Parkinson's Disease Patients Living in Lombardy Incidence of Anxiety in Parkinson's Disease During the Coronavirus Disease (COVID-19) Pandemic Cognitive impairment in Parkinson's disease: a report from a multidisciplinary symposium on unmet needs and future directions to maintain cognitive health This article is protected by copyright. All rights reserved.